About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1NCT04083716

A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

This study is designed to assess the relative bioavailability of ABI-H2158 tablets (Test Formulation) compared to ABI-H2158 tablets (Reference Formulation). The effect of food on the pharmacokinetics ...

Lead sponsor: Assembly Biosciences•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Assembly Biosciences

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1\. No clinically significant abnormal findings on physical exam, medical history, or clinical laboratory results at screening.

Exclusion Criteria

•1. Positive test results for human immunodeficiency virus (HIV) or hepatitis B or C.
•2. Treatment for drug or alcohol dependence.

Related studies

RECRUITINGPhase 2

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

NCT06092333 · Chronic Hepatitis B

RECRUITINGPhase 2

A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis

RECRUITINGPhase 2

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

NCT02932150 · Chronic Hepatitis B

RECRUITINGPhase 3

A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis

NCT07343778 · Chronic Hepatitis B With Hepatic Fibrosis

RECRUITINGPhase 1

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

NCT06671093 · Chronic Hep B, Chronic Hepatitis b, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 29, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment15

Start dateSep 2019

Last updatedNov 29, 2019

Condition

Chronic Hepatitis B

Locations shown

Celerion

Tempe, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 29, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions